Physical Therapists in Eastland, TX Accepting Medicare
7 Physical Therapists found. Showing 1 - 7
 Mrs. Kathryn Jo Roby, PT Physical Therapist - Orthopedic Medicare: Medicare Enrolled Practice Location: 304 S Daugherty Ave, Eastland, TX 76448 Phone: 254-631-5358 |
Kimberly Diane Stieber, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 304 S Daugherty Ave, Eastland, TX 76448 Phone: 254-631-5358 Fax: 254-631-0819 |
 Mitchell Akers, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 304 S Daugherty Ave, Eastland, TX 76448 Phone: 254-631-5358 |
Brooke Rawlings, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 304 S Daugherty Ave, Eastland, TX 76448 Phone: 254-631-5358 |
Mrs. Monica Leticia Harris, PT, MS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 304 S Daugherty Ave, Eastland, TX 76448 Phone: 254-631-5358 |
Dr. John Castanuela, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 304 S Daugherty Ave, Eastland, TX 76448 Phone: 254-631-5358 |
Mrs. Mary Makenzie Akers, PTA Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 304 S Daugherty Ave, Eastland, TX 76448 Phone: 254-631-5358 Fax: 254-631-0819 |
News Archive
$650 million funding from HHS to benefit black and Latino communities
The health of the nation's black and Latino communities stands to get a significant shot in the arm from the $650 million in health and wellness funding announced this afternoon by the Department of Health and Human Services, according to PolicyLink, a national research and advocacy organization.
Eisai's eribulin mesylate improves median OS compared with TPC in pre-treated metastatic breast cancer patients
Results of a Phase III study presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's eribulin mesylate significantly improved median overall survival (OS) compared with Treatment of Physician's Choice (TPC) in heavily pre-treated metastatic breast cancer patients.
GLNT receives allowance of patent for Parkinson's disease monitoring technology
Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company's fourth in the past eight months focused on technology for Parkinson's disease diagnostics and treatment.
Synaptic levels of protein clathrin are determinant factor for plasticity of neurons
Researchers of the group of cellular and molecular neurobiology of the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona, led by researcher Artur Llobet, have shown that synaptic levels of the protein clathrin are a determinant factor for synaptic plasticity of neurons.
Five-stage reverse osmosis best for removal of hexavalent chromium from drinking water
The only way to learn if your water source has hexavalent chromium is to check with your public water supplier and request a water quality report, said NJIT Professor Taha Marhaba, a civil/environmental engineer. Most municipal or city engineers should be able to provide such a report upon request. Additional information specifically about hexavalent chromium levels may also be available.
› Verified 9 days ago
Physical Therapists
Chiropractors
Optometrists
Occupational Therapists
Speech-Language Pathologists